Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04395144 Completed - Respiratory Failure Clinical Trials

COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss

COVAYDE
Start date: May 15, 2020
Phase: N/A
Study type: Interventional

Prone positioning is an established intervention in mechanically ventilated acute respiratory distress syndrome (ARDS) patients, with demonstrated reductions in mortality. Preliminary data suggest that awake proning in patients with COVID-19 treated with high-flow nasal oxygenation (HFNO) improves gas exchanges, and might be associated with a reduced need of mechanical ventilation, and reduced mortality. Further investigation in a formal randomized-controlled trial is need.

NCT ID: NCT04394715 Completed - Clinical trials for High Risk Atherosclerotic Cardiovascular Disease

Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study is designed to evaluate the efficacy of automated electronic alerts in the electronic health record to improve rates of best practices in the treatment of patients with hyperlipidemia who present in the setting of outpatient primary care and family medicine practices within the Yale New Haven Health System.

NCT ID: NCT04393506 Completed - Oral Cancer Clinical Trials

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Start date: April 23, 2020
Phase: Phase 1
Study type: Interventional

In patients with locally advanced oral squamous cell carcinoma (OSCC), due to the large tumor burden and neck lymph node metastasis, comprehensive treatment is recommended, including surgery, radiotherapy, chemotherapy and others. Pre-operative inductive therapy can reduce tumor volume, increase organ retention rate, and reduce distant metastasis rate. Vascular endothelial growth factor (VEGF) receptor in head and neck squamous cell carcinoma is over-expressed and associated with disease invasion and poor prognosis. The use of targeted therapy against VEGF can not only inhibit tumor neovascularization, but also make the effectiveness of chemotherapeutic agents. VEGF and VEGFR are closely related to immune escape. Tumor growth requires new blood vessels to supply nutrients and oxygen, and VEGF can stimulate neovascularization. However, tumor neovascularization is often abnormal and distorted, which prevents immune active substances from reaching the tumor site. After tumor hypoxia, high expression of VEGF will induce tumor cells to express programmed cell death protein-1 (PD-1), which further leads to immune escape. Targeted drugs against angiogenesis can relieve immunosuppression to a certain extent, and theoretically have a synergistic effect with anti-PD-1 immunotherapy. The innovation of this study is the combination of immune checkpoint inhibitor, Camrelizumab, and targeted drug against VEGFR, Apatinib, as an inductive therapy to treat the patients with locally advanced OSCC, followed with radical surgery and post-operative radiotherapy/chemoradiotherapy, the major pathologic response and safety will be evaluated as the primary surrogate endpoints, the 2-year survival rate and local recurrence rate will be the second endpoints.

NCT ID: NCT04393480 Completed - Clinical trials for Hemiplegia and/or Hemiparesis Following Stroke

Upper Extremity Robotic Rehabilitation in Patients With Hemiplegia

Start date: April 14, 2016
Phase: N/A
Study type: Interventional

Comparison of Upper Extremity Robotic Rehabilitation Efficiency with Conventional Rehabilitation in Patients with Hemiplegia after Cerebrovascular Event

NCT ID: NCT04393220 Completed - Clinical trials for Progress Free Survival (PFS) and Overall Survival (OS)

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Start date: May 11, 2020
Phase: Phase 2
Study type: Interventional

The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.

NCT ID: NCT04393129 Completed - Clinical trials for Anterior Cruciate Ligament Rupture

Central Sensitization Symptoms and Psychosocial Factors in Athletes After ACL Reconstruction

Start date: October 1, 2019
Phase:
Study type: Observational

The main research objective of this study is whether athletes who have sustained an anterior cruciate ligament injury, experience chronic nociplastic pain and psychosocial factors, including kinesiophobia and pain catastrophizing, after having been through ACL reconstruction surgery and rehabilitation and have returned to sport.

NCT ID: NCT04393012 Completed - Clinical trials for Problems With Access to Health Care

Providing Access to an Alternative Nurse Call

Start date: April 1, 2016
Phase: N/A
Study type: Interventional

To address the needs of the many patients who cannot access the standard nurse call systems Iowa Adaptive Technologies has developed the Noddle, a smart switch that can take the smallest intentional gesture a patient can make (e.g. tongue click, wink) and allow the patient to access the nurse call system and control a speech-generating device. This study will assess how patients and their nurses as well as family members perceive the impact of having a device that would allow them to summon the nurse and to be able to effectively communicate. Patients will be provided a Noddle and will be free to use it as much or a little as they like during their hospitalization. Patients will either use the Noddle just to access the nurse call system or they will use it to access the nurse call system and a speech-generating device. Patients, nurses and family members will be asked to complete an exit questionnaire prior to discharge from the hospital.

NCT ID: NCT04392817 Completed - Clinical trials for Velopharyngeal Insufficiency

Efficacy of an Arabic Articulatory Error Remediation Software Program in Patients With Velopharyngeal Valve Dysfunction:

Start date: January 2, 2018
Phase: N/A
Study type: Interventional

To develop a remediation software program that is specific for correcting speech errors in patients with velopharyngeal dysfunction in the Arabic language and test its efficacy, on one group comparing pre and post results

NCT ID: NCT04392661 Completed - Clinical trials for Female Fertility and Bariatric Surgery

Female Fertility Outcome Following Bariatric Surgery: Five Years Follow up

Start date: January 2012
Phase:
Study type: Observational

Maternal morbid obesity is an important risk factor in modern obstetrics, it has been associated with higher infertility rates and obstetrics complications. Bariatric surgery proven to achieve long term weight loss with improvement in all obesity related morbidities. This study was to compare the 5 years outcomes of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in terms of fertility outcomes, breast feeding, weight loss, safety, and resolution of obesity related co-morbidity.

NCT ID: NCT04392336 Completed - Clinical trials for Impact of Feedback on Symptoms and Trust/Respect on Outcomes

Tracking and Improving Trust/Respect

Start date: September 27, 2019
Phase: N/A
Study type: Interventional

This study will examine the efficacy of a feedback system for providers that tracks patient trust/respect on an ongoing basis and to test the hypothesis that receiving feedback on trust/respect will lead to improvements in patient satisfaction, functioning, symptoms, and trust/respect. .